Lowering Insulin to Reduce Fat Buildup in the Liver
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests if lowering insulin levels can reduce fat buildup in the liver for people with a fatty liver condition called MASLD. It's looking for adults who are overweight and have early signs of insulin resistance but not diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 30 and 45.
- You have a fatty liver condition (MASLD) without advanced scarring.
- You have signs of insulin resistance, like prediabetes or high fasting insulin.
- You have not had bariatric surgery in the past year (like gastric bypass or sleeve).
- You do not have diabetes, heart disease, or other serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how your body responds to insulin by using a special test called a pancreatic clamp. It may help researchers understand insulin resistance better and find new ways to treat it.
This study tests how “lipid” (fat) changes in the body affect insulin resistance, which is when the body doesn’t respond to insulin as well as it should. Because it’s done in healthy people, it’s mainly looking at basic biology and may help guide future treatments.
This study tests whether reducing liver fat can improve health in people with type 2 diabetes. It looks at the effects of a specific medication combined with exercise, tailored for those who are not very active.
This study looks at how differences in insulin resistance may change how the liver makes triglycerides (a type of blood fat). It may help researchers understand why some people have higher triglycerides and how to target them better.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study tests whether a daily ketone ester drink can reduce liver fat and improve metabolism in people with excess liver fat. You may join if you are 18–40, have overweight or obesity, and your liver has extra fat.
Hear when a new Hyperinsulinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.